Lincare Holdings (LNCR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lincare Holdings (LNCR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: John Stichnoth who wrote ()	5/31/2000 4:54:00 PM
From: kendall harmon	of 6

LNCR, overdone on the downside today dow jones excerpts <<...several analysts labeled the selloff in Lincare shares an overreaction by investors. They said the company earns the bulk of its revenue from liquid oxygen systems and other respiratory equipment and gets only a small portion from drugs. "I can't see how this is going to have a major earnings impact" on Lincare, said Christopher Caton, an analyst with Robert W. Baird & Co. John Hindelong, an analyst with Donaldson Lufkin & Jenrette Securities Corp., agreed. "It's highly unlikely" that the potential cuts will have a big impact on Lincare, Hindelong said. Caton rates Lincare a strong buy, while Hindelong rates it a buy.>>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext